Reducing False Out-of-Control Signals
Control charts that are properly constructed and maintained prevent false out-of-control signals and provide a useful method for monitoring a process. More... |
| |
| |
| |
Comparing Manufacturing Process Options
A techno-economic profiling method supports pharmaceutical process development by helping identify the best manufacturing approach.
More... |
| |
| Top Stories |
| |
Ebola Outbreak Raises Ethical Issues
The recent outbreak of the Ebola virus has escalated testing of high-risk compounds and raised questions about the ethics of testing unproven medicines and which patients should have access to the therapies. More... |
| |
Guilty Plea to Importing Illegal Cancer Drugs
The owner of an Istanbul-Turkey drug company has pleaded guilty to charges of smuggling a misbranded and adulterated version of Avastin. More... |
| |
FDA Issues Warning Letter to India's Marck Biosciences
FDA found violations of cGMP at finished-drug manufacturer in India. More... |
| |
|
PharmTech Europe Marks 25 Years of Drug Development |
Supply-Chain Security of Pharmaceutical Starting Materials
IPEC Europe continues to promote the quality, safety and functionality of excipients used in pharmaceutical products. More... |
| |
Supply-Chain Security from a European Perspective
Global harmonisation would help improve supply-chain security and reduce the flow of falsified and sub-standard medicine into Europe. More... |
| |
|
Pharma Collaborations |
AstraZeneca and Mitsubishi Tanabe Pharma Collaborate in Diabetic Nephropathy
The companies will research small-molecule candidate drugs for diabetic nephropathy. More... |
| |
Bristol-Myers Squibb and Celgene Collaborate on Immunotherapy and Chemotherapy Combination Regimen
The companies will conduct clinical trials to evaluate a combination immune checkpoint inhibitor and a chemotherapy drug. More... |
| |
Capsugel and Cardax Collaborate on Astaxanthin Products
Collaboration leverages Capsugel's proprietary lipid-based technologies for potential development of consumer health products. More... |
| |
|
Industry News |
Gallus to Manufacture Anti-PSMA mAb for Progenics Pharmaceuticals
Gallus BioPharmaceuticals will manufacture the anti-prostate specific membrane antigen monoclonal antibody used in Progenics Pharmaceuticals’ PSMA ADC product candidate. More... |
| |
WuXi Facility Passes FDA Inspection for Manufacture of API
Shanghai SynTheAll Pharmaceutical facility passed inspections for API and advanced intermediate manufacture. More... |
| |
Fujifilm Diosynth Biotechnologies Expands Cell-Culture Capacity
Additional single-use bioreactors will meet demand and offer a low-risk route to market. More... |
| |
GE Healthcare Life Sciences Announces New US Headquarters in Massachusetts
The new US headquarters for GE Healthcare Life Sciences in Marlborough, Mass. will house more than 500 employees. More... |
| |
Catalent Appoints Two Executives to Board of Directors
Catalent names Jack Stahl and Rolf Classon to board of directors. More... |
| |
